0001140361-24-031291.txt : 20240625 0001140361-24-031291.hdr.sgml : 20240625 20240625160508 ACCESSION NUMBER: 0001140361-24-031291 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240624 FILED AS OF DATE: 20240625 DATE AS OF CHANGE: 20240625 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Iliev Ilian CENTRAL INDEX KEY: 0001808804 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37568 FILM NUMBER: 241068926 MAIL ADDRESS: STREET 1: 303 A COLLEGE ROAD EAST CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PDS Biotechnology Corp CENTRAL INDEX KEY: 0001472091 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 264231384 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 303A COLLEGE ROAD EAST CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 800-208-3343 MAIL ADDRESS: STREET 1: 303A COLLEGE ROAD EAST CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: Edge Therapeutics, Inc. DATE OF NAME CHANGE: 20090911 4 1 form4.xml FORM 4 X0508 4 2024-06-24 0001472091 PDS Biotechnology Corp PDSB 0001808804 Iliev Ilian C/O PDS BIOTECHNOLOGY CORPORATION 303A COLLEGE ROAD EAST PRINCETON NJ 08540 true false Employee Stock Option (Right to Buy) 2.86 2024-06-24 4 A 0 9000 0 A 2034-06-24 Common Stock 9000 9000 D The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date. /s/ Spencer Brown, as Attorney-in-Fact 2024-06-25